NXSTAGE PUREFLOW SOLUTION RFP-207-CAN
Google image searchProduct monograph
Active ingredients
sodium lactate, 8.408 G/L
calcium chloride, 0.221 G/L
potassium chloride, 0.075 G/L
dextrose, 1.1 G/L
magnesium chloride, 0.102 G/L
sodium chloride, 5.552 G/L
DIN: 02443287
Dosage form(s): SOLUTION
Route(s) of administration: HAEMODIALYSIS
Schedule: Ethical
Company: NXSTAGE MEDICAL INC
Date: 15-SEP-2016
ATC:
- B05 — BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS (ATC, ATC/DDD, )
- B05Z — HEMODIALYTICS AND HEMOFILTRATES (ATC, ATC/DDD)
- B05ZA — Hemodialytics, concentrates (ATC, ATC/DDD)
External Links for Nxstage Pureflow Solution Rfp-207-Can
Search on Google
- Nxstage Pureflow Solution Rfp-207-Can side effects
- Nxstage Pureflow Solution Rfp-207-Can dosage
- sodium lactate side effects
- sodium lactate dosage
- calcium chloride side effects
- calcium chloride dosage
- potassium chloride side effects
- potassium chloride dosage
- dextrose side effects
- dextrose dosage
- magnesium chloride side effects
- magnesium chloride dosage
- sodium chloride side effects
- sodium chloride dosage